Indications
Qtrilmet is indicated in adults aged 18 years and older with type 2 diabetes mellitus: to improve glycaemic control when metformin with or without sulphonylurea (SU) and either saxagliptin or dapagliflozin does not provide adequate glycaemic control. when already being treated with metformin and saxagliptin and dapagliflozin.
Composition
- Active substance
- metformin hydrochloride, saxagliptin, dapagliflozin
- International name (INN)
- metformin hydrochloride;saxagliptin;dapagliflozin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Qtrilmet
- Active substance
- metformin hydrochloride, saxagliptin, dapagliflozin
- ATC code
- A10BD